BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38294237)

  • 1. Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug-resistant
    Harrison GA; Wang ER; Cho K; Mreyoud Y; Sarkar S; Almqvist F; Patti GJ; Stallings CL
    mBio; 2024 Mar; 15(3):e0296823. PubMed ID: 38294237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug resistant
    Harrison GA; Cho K; Wang ER; Sarkar S; Almqvist F; Patti GJ; Stallings CL
    bioRxiv; 2023 Feb; ():. PubMed ID: 36798348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
    Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
    J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
    Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.
    Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y
    Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
    Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
    Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on the Mechanism of Action of INH-C
    Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
    Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
    Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA
    Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
    Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical disarming of isoniazid resistance in
    Flentie K; Harrison GA; Tükenmez H; Livny J; Good JAD; Sarkar S; Zhu DX; Kinsella RL; Weiss LA; Solomon SD; Schene ME; Hansen MR; Cairns AG; Kulén M; Wixe T; Lindgren AEG; Chorell E; Bengtsson C; Krishnan KS; Hultgren SJ; Larsson C; Almqvist F; Stallings CL
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10510-10517. PubMed ID: 31061116
    [No Abstract]   [Full Text] [Related]  

  • 14. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance.
    Rawat R; Whitty A; Tonge PJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13881-6. PubMed ID: 14623976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of novel
    Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
    Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
    Torres JN; Paul LV; Rodwell TC; Victor TC; Amallraja AM; Elghraoui A; Goodmanson AP; Ramirez-Busby SM; Chawla A; Zadorozhny V; Streicher EM; Sirgel FA; Catanzaro D; Rodrigues C; Gler MT; Crudu V; Catanzaro A; Valafar F
    Emerg Microbes Infect; 2015 Jul; 4(7):e42. PubMed ID: 26251830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
    Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
    Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.
    Morlock GP; Metchock B; Sikes D; Crawford JT; Cooksey RC
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3799-805. PubMed ID: 14638486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
    Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the coexistence of non-codon 315 katG, inhA, and oxyR-ahpC intergenic gene mutations among isoniazid-resistant and multidrug-resistant isolates of Mycobacterium tuberculosis: a report of novel mutations.
    Norouzi F; Moghim S; Farzaneh S; Fazeli H; Salehi M; Nasr Esfahani B
    Pathog Glob Health; 2022 Feb; 116(1):22-29. PubMed ID: 34086544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.